Sahu and colleagues found the mechanism which leads to melanoma tumor progression is due to the systemic expression and activation of PAFR; and that whether the tumor cells themselves expressed PAFR or not does not impact the tumor development, suggesting that PAFR-mediated anti-tumoral immunity effects are involved (130). Here, PTAFR is linked to neoplasm.